Allogeneic Cell Therapy Market to Hit USD 3.29 Billion by 2032; Breakthroughs in "Off-the-Shelf" Solutions Set to Revolutionize Oncology and Immunology The landscape of regenerative medicine is shifting from personalized treatments to scalable, universal solutions. According to the latest strategic industry report by Maximize Market Research, the Allogeneic Cell Therapy Market, which was...